No results for ‘’
Alkem Laboratories Ltd
₹5436.50
(0.61%)
Fri, 29 May 2026, 05:44 am
Health Technology
Pharmaceuticals: Major
24.5KAlkem Laboratories Shareholding
| Shareholders | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 |
|---|---|---|---|---|---|
| Promoters | 51.20 | 51.20 | 51.20 | 53.04 | 55.13 |
| FII | 10.16 | 9.97 | 9.48 | 9.11 | 9.41 |
| DII | 21.40 | 21.54 | 21.93 | 21.80 | 19.42 |
| Public | 17.25 | 17.30 | 17.40 | 16.05 | 16.05 |
| Government | 0 | 0 | 0 | 0 | 0.00 |
Alkem Laboratories Ltd Shareholding Pattern
The Alkem Laboratories Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Alkem Laboratories Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.
Alkem Laboratories Ltd (NSE: ALKEM, BSE: 539523) operates in the Health technology sector and Pharmaceuticals: major industry. Monitoring the Alkem Laboratories Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.
Alkem Laboratories Ltd Shareholding Pattern (Latest)
The latest Alkem Laboratories Ltd shareholding for Mar 2026 is:
- Promoters: 51.20%
- FII: 10.16%
- DII: 21.40%
- Public: 17.25%
- Government: 0%
Promoter holding in Alkem Laboratories Ltd remains stable, reflecting consistent long-term commitment.
Alkem Laboratories Ltd Promoter Holding Trend
Promoter shareholding plays a crucial role in evaluating management confidence in Alkem Laboratories Ltd.
- Mar 2026: 51.20%
- Dec 2025: 51.20%
- Sept 2025: 51.20%
- Jun 2025: 53.04%
- Mar 2025: 55.13%
Promoter stake remains largely stable, showing consistent ownership structure.
Alkem Laboratories Ltd FII Shareholding Trend
Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Alkem Laboratories Ltd.
- Mar 2026: 10.16%
- Dec 2025: 9.97%
- Sept 2025: 9.48%
- Jun 2025: 9.11%
- Mar 2025: 9.41%
FII holding in Alkem Laboratories Ltd has increased recently, indicating rising foreign investor interest.
Alkem Laboratories Ltd DII Shareholding Trend
Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.
- Mar 2026: 21.40%
- Dec 2025: 21.54%
- Sept 2025: 21.93%
- Jun 2025: 21.80%
- Mar 2025: 19.42%
DII holdings remain stable, reflecting steady institutional participation.
Alkem Laboratories Ltd Public Shareholding Trend
Public shareholding represents retail and non-institutional investors.
- Mar 2026: 17.25%
- Dec 2025: 17.30%
- Sept 2025: 17.40%
- Jun 2025: 16.05%
- Mar 2025: 16.05%
Public holding remains stable with consistent retail participation.
Alkem Laboratories Ltd Government Holding
Government holding in Alkem Laboratories Ltd currently stands at 0%.
Alkem Laboratories Ltd operates without significant government ownership.
Alkem Laboratories Ltd Shareholding Analysis Summary
The Alkem Laboratories Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.
Alkem Laboratories Ltd shows strong promoter and domestic institutional confidence, which is positive for long-term investors.
Regular monitoring of the Alkem Laboratories Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.